Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Effects of Panax ginseng on hyperglycemia, hypertension, and hyperlipidemia: A systematic review and meta-analysis.

  • 2022-03
  • Journal of ginseng research 46(2)
    • Soo Hyun Park
    • Sangwon Chung
    • Min-Yu Chung
    • Hyo-Kyoung Choi
    • Jin-Taek Hwang
    • Jae Ho Park

Study Design

Type
Review
Sample size
n = 23
Population
healthy adults to those with diabetes, hypertension, obesity, and/or hyperlipidemia
Methods
Systematic review and meta-analysis of 23 papers (27 datasets) investigating P. ginseng supplementation (dose 200 mg to 8 g, duration 4 to 24 weeks) on metabolic parameters
Duration
4 to 24 weeks
Panax ginseng is a medicinal plant is a material with various pharmacological activities and research suggests that it is particularly effective in representative metabolic diseases such as hyperglycemia, hypertension, and hyperlipidemia. Therefore, in this study, systematic review and meta-analysis were performed to investigate the comprehensive effect of P. ginseng on metabolic parameters representing these metabolic diseases. A total of 23 papers were collected for inclusion in the study, from which 27 datasets were collected. The investigational products included P. ginseng and Korean Red ginseng. Across the included studies, the dose ranged from 200 mg to 8 g and the supplementation period lasted from four to 24 weeks. The study subjects varied from healthy adults to those with diabetes, hypertension, obesity, and/or hyperlipidemia. As a result of the analysis, the levels of glucose and insulin area under the curves, % body fat, systolic and diastolic blood pressures, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were significantly reduced in the P. ginseng group as compared with in the placebo group. In conclusion, P. ginseng supplementation may act as an adjuvant to prevent the development of metabolic diseases by improving markers related to blood glucose, blood pressure, and blood lipids.

Research Insights

  • the levels of glucose and insulin area under the curves, % body fat, systolic and diastolic blood pressures, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were significantly reduced in the P. ginseng group as compared with in the placebo group

    Effect
    Beneficial
    Effect size
    Small
    Dose
    200 mg to 8 g
  • the levels of glucose and insulin area under the curves, % body fat, systolic and diastolic blood pressures, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were significantly reduced in the P. ginseng group as compared with in the placebo group

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    200 mg to 8 g
  • As a result of the analysis, the levels of glucose and insulin area under the curves, % body fat, systolic and diastolic blood pressures, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were significantly reduced in the P. ginseng group as compared with in the placebo group.

    Effect
    Beneficial
    Effect size
    Small
    Dose
    200 mg to 8 g daily
  • the levels of glucose and insulin area under the curves, % body fat, systolic and diastolic blood pressures, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were significantly reduced in the P. ginseng group as compared with in the placebo group

    Effect
    Beneficial
    Effect size
    Small
    Dose
    200 mg to 8 g
  • As a result of the analysis, the levels of glucose and insulin area under the curves, % body fat, systolic and diastolic blood pressures, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were significantly reduced in the P. ginseng group as compared with in the placebo group.

    Effect
    Beneficial
    Effect size
    Small
    Dose
    200 mg to 8 g daily
  • As a result of the analysis, the levels of glucose and insulin area under the curves, % body fat, systolic and diastolic blood pressures, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were significantly reduced in the P. ginseng group as compared with in the placebo group.

    Effect
    Beneficial
    Effect size
    Small
    Dose
    200 mg to 8 g daily
  • the levels of glucose and insulin area under the curves, % body fat, systolic and diastolic blood pressures, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were significantly reduced in the P. ginseng group as compared with in the placebo group

    Effect
    Beneficial
    Effect size
    Small
    Dose
    200 mg to 8 g
  • the levels of glucose and insulin area under the curves, % body fat, systolic and diastolic blood pressures, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were significantly reduced in the P. ginseng group as compared with in the placebo group

    Effect
    Beneficial
    Effect size
    Small
    Dose
    200 mg to 8 g
  • the levels of glucose and insulin area under the curves, % body fat, systolic and diastolic blood pressures, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were significantly reduced in the P. ginseng group as compared with in the placebo group

    Effect
    Beneficial
    Effect size
    Small
    Dose
    200 mg to 8 g
Back to top